Belinda Peregrin recommends DS Healthcare’s Revita

Pompano Beach Fla., June 12, 2015 (GLOBE NEWSWIRE) -- Through her Twitter account where she is simply known as Belinda, Ms. Peregrín posted a message to her 3.6 million followers: “I love how much my hair grew with Revita” (translated from Spanish).

Mexico is the fastest growing market for DS Healthcare’s consumer products and this endorsement further increases awareness of the DS Laboratories brand and innovation. In Mexico, the entire line of DS Healthcare’s hair loss products is recommended and prescribed by doctors and distributed through upscale pharmacy chains. Both men and women turn to these treatments to treat hair loss and many are proactive and use these products to promote optimal scalp health for healthy hair growth.

Revita® is a comprehensive therapy for the scalp that utilizes DS Healthcare’s multi-later approach to targeting multiple underlying factors that trigger hair loss. Despite its potent therapeutic benefits, Revita® is developed with a unique surfactant system that also provides outstanding cosmetic benefits and the lowest irritation potential when in contact with the skin. In a laboratory study, Revita® was shown to be gentler and less irritating to skin than Johnson’s Baby Shampoo.

To try DS Healthcare’s Revita® follow this link to purchase:

About DS Healthcare Group

DS Healthcare Group Inc. (NASDAQ:DSKX) leads in the development of biotechnology for topical therapies. It markets through online and specialty retailers, distributors, cosmetics wholesalers, salons and pharmacies. Its research has led to a highly innovative portfolio of personal care products and additional innovations in pharmaceutical projects. For more information on DS Health Group's flagship brand, visit

Forward-looking statements

Except for statements of historical fact, the matters discussed in this press release are forward-looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies, and are generally preceded by words such as "future," "plan" or "planned," "expects," or "projected." These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond the company's control that may cause actual results to differ materially from stated expectations. These risk factors include, among others, limited operating history, difficulty in developing and marketing products, intense competition, and additional risks factors as discussed in reports filed by the company with the Securities and Exchange Commission, which are available at

Abner Silva DS Healthcare Group 407.342.4112

Source:DS Healthcare Group, Inc.